Carryfine SR 300 Tablet
By Carryfine
Rx
10 Tablet SR in a Strip

Composition
Progesterone(300mg)

Manufacturer - Aquinnova Pharmaceuticals Private Limited
95 SAKET DHAM GANDHI NAGAR INDORE Indore MP 452005 IN

Expires on or after
September, 2025
About Carryfine SR 300 Tablet
Carryfine SR 300 Tablet is a natural female sex hormone known as progesterone. It is commonly used to address menstrual and pregnancy-related issues that result from hormonal imbalances. Additionally, Carryfine SR 300 Tablet is often prescribed in conjunction with estrogen as part of hormonal replacement therapy to help prevent endometrial hyperplasia, which is the thickening of the lining of the uterus.
When taking Carryfine SR 300 Tablet, it is recommended to do so without food, ideally in the evening or at bedtime. Consistency in the timing of intake is crucial for optimal effectiveness. Even if symptoms improve, it is essential to adhere to the prescribed duration of treatment as advised by your healthcare provider.
Like with any medication, there are potential side effects associated with Carryfine SR 300 Tablet. These may include abdominal bloating, pain, dizziness, headaches, mood changes, breast tenderness, hot flashes, vaginal discharge, joint pain, and urinary incontinence. Usually, side effects are more pronounced in the initial weeks of treatment and tend to diminish as the body adjusts to the medication. It is important to seek medical advice if experiencing frequent bleeding between periods or if notable dizziness or fatigue occurs, as driving or activities requiring concentration may need to be avoided.
Prior to starting treatment with Carryfine SR 300 Tablet, inform your doctor if you have a history of breast cancer, unusual vaginal bleeding, or liver disease. Various tests may be conducted before and during treatment to monitor your condition. It is also essential to disclose all other medications being taken to ensure compatibility with Carryfine SR 300 Tablet.
Carryfine SR 300 Tablet 10's falls under the category of female hormones used alongside estrogen for hormone replacement therapy. Besides this primary function, the tablet is also effective in treating amenorrhoea and preventing endometrial hyperplasia. Additionally, it aids in the maintenance of pregnancy, managing threatened abortion, and preventing preterm labor. Hormone replacement therapy aims to alleviate menopausal symptoms by replenishing hormone levels that decline with age.
Containing progesterone, Carryfine SR 300 Tablet 10's acts by restoring estrogen and progesterone levels in the body, providing relief from menopausal symptoms. Following the prescribed regimen is important, and potential side effects like dizziness, drowsiness, mood changes, and other symptoms are usually temporary and self-resolving. It is advisable to consult your healthcare provider if side effects persist or worsen.
Individuals allergic to soya or any component in the tablet should notify their doctor. Moreover, precautions should be taken if one has conditions such as breast cancer, unexplained vaginal bleeding, blood clotting disorders, liver disease, porphyria, or cerebral hemorrhage. Pregnant women should avoid taking Carryfine SR 300 Tablet 10's to prevent any harm to the unborn baby. Effective birth control methods are recommended while using the medication to prevent pregnancy. Always consult a healthcare professional before taking this medication if you are pregnant, planning to become pregnant, or breastfeeding, as safety considerations are crucial. Additionally, caution is advised when driving due to potential drowsiness or dizziness as a side effect of Carryfine SR 300 Tablet 10's.
Benefits
Carryfine SR 300 Tablet offers significant benefits for Hormone Replacement Therapy (HRT) and in the treatment of female infertility. In HRT, this medication is used to alleviate uncomfortable symptoms associated with menopause such as hot flushes, night sweats, mood swings, vaginal dryness, and reduced sex drive. Menopause, which can last for an extended period, can greatly impact daily life and mood, and Carryfine SR 300 Tablet can provide a substantial improvement in quality of life when taken as prescribed by a doctor.
For female infertility, Carryfine SR 300 Tablet contains progesterone, a vital female hormone that plays a key role in regulating ovulation and menstruation. This medication is particularly helpful for women who are not experiencing periods due to a lack of natural progesterone in the body. Progesterone helps to prepare the uterus for pregnancy by thickening the uterine lining, known as the endometrium. By enhancing the chances of a successful pregnancy, Carryfine SR 300 Tablet proves to be an effective treatment option. It is essential to follow the prescribed dosage regimen to ensure optimal effectiveness. Additionally, continuing with the treatment for a specified period after conception may be recommended for the best outcomes.
How to use the Carryfine SR 300 Tablet
To properly use Carryfine SR 300 Tablet, follow your doctor's instructions on dosage and duration. Swallow the tablet whole without chewing, crushing, or breaking it. It is important to take Carryfine SR 300 Tablet on an empty stomach for best results. Remember to not alter the tablet in any way before consuming it. If you need further clarification on how to use this medication, consult your healthcare provider for guidance.
Uses of Carryfine SR 300 Tablet
Carryfine SR 300 Tablet is commonly used for hormone replacement therapy in women. It is also prescribed to treat female infertility. These tablets are specifically recommended to help in regulating hormone levels and supporting reproductive health in women facing infertility issues. By addressing hormone imbalances and aiding in fertility, Carryfine SR 300 Tablet plays a vital role in assisting women in their journey towards achieving pregnancy.
What conditions Carryfine SR 300 Tablet treats?
Carryfine SR 300 Tablet is a medication containing progesterone, a female hormone. It is used to treat menstrual and pregnancy-related issues caused by hormonal imbalance. It is also prescribed in combination with estrogen for hormonal replacement therapy to prevent endometrial hyperplasia. Common side effects include abdominal bloating, headache, breast tenderness, and vaginal discharge. Inform your doctor of any history of breast cancer, vaginal bleeding, or liver disease before taking this medication, as it may require monitoring. Consult your doctor if side effects persist or worsen.
Should you consult a doctor?
If you experience unusual vaginal bleeding, abdominal pain, severe headache, or persistent dizziness while taking Carryfine SR 300 Tablet, you should seek medical assistance promptly. Additionally, if you notice symptoms such as slurred speech, pain behind the eyes, or vertigo, it is essential to consult your doctor. Do not ignore persistent side effects like hot flushes, urinary incontinence, or abnormal menstrual bleeding. It is also crucial to inform your healthcare provider if you have a history of breast cancer, liver disease, or any other concerning medical conditions before starting this medication. Always communicate any new symptoms or concerns to your doctor, especially if they persist or worsen over time. Regular monitoring and open communication with your healthcare provider are important for ensuring the safe and effective use of Carryfine SR 300 Tablet.
Side effects of Carryfine SR 300 Tablet
When taking Carryfine SR 300 Tablet, you may experience certain side effects. These effects, such as abdominal bloating, hot flushes, and vaginal discharge, are common and usually temporary. Other possible side effects include urinary incontinence, headache, fatigue, joint pain, cough, and abnormal menstrual bleeding. Additionally, you may also encounter musculoskeletal pain, slurred speech, pain behind the eyes, and vertigo. Remember, most of these side effects will fade as your body gets used to the medication. However, if any of these effects persist or cause concern, it is important to consult your doctor for guidance and appropriate management.
Safety advice

liver
Limited information is present regarding the use of Carryfine SR 300 Tablet in individuals with liver conditions. It is advised to consult your doctor before using this medication if you have liver issues. It is not recommended to use Carryfine SR 300 Tablet in cases of severe liver disease.

kidney
There is limited information available on using Carryfine SR 300 Tablet in patients with kidney disease. Please consult your doctor for proper guidance.

alcohol
Consult your doctor when consuming alcohol with Carryfine SR 300 Tablet.

driving
Carryfine SR 300 Tablet may reduce alertness, impact vision, and cause drowsiness and dizziness. Avoid driving if experiencing these effects.

pregnancy
Carryfine SR 300 Tablet is considered safe for use during pregnancy. Studies suggest minimal risk to the baby's development.

breastfeeding
Carryfine SR 300 Tablet is considered safe to use while breastfeeding. Research shows the medication does not pass into breastmilk in harmful levels.
Consumption warning before consuming Carryfine SR 300 Tablet
Before consuming Carryfine SR 300 Tablet, it is important to note that this medication contains progesterone, a natural female sex hormone. It is commonly used to address menstrual and pregnancy-related issues resulting from hormonal imbalances. This tablet may also be prescribed in combination with estrogen for hormonal replacement therapy to prevent endometrial hyperplasia.
To ensure optimal effectiveness, it is recommended to take Carryfine SR 300 Tablet without food, ideally in the evening or at bedtime, consistently at the same time each day as advised by your healthcare provider. Even if you start feeling better, it is crucial to continue taking the medication for the duration specified by your doctor.
Potential side effects may include abdominal bloating, pain, dizziness, headache, mood changes, breast tenderness, hot flashes, vaginal discharge, joint pain, and urinary incontinence. These side effects are more prevalent during the initial stages of treatment and often diminish as the body adjusts. Consult your doctor if you experience abnormal bleeding between periods or if dizziness or fatigue occurs, as it may affect your ability to perform tasks requiring concentration.
Essential information to disclose to your doctor before starting the treatment with Carryfine SR 300 Tablet includes a history of breast cancer, unusual vaginal bleeding, or liver disease. Regular tests may be conducted before and during treatment to monitor your condition. Also, inform your doctor about all other medications you are taking to avoid any potential interactions.
Related lab tests
Related Lab Tests:
When taking Carryfine SR 300 Tablet, there are certain lab tests that may be important to monitor. These tests can help your healthcare provider assess how your body is responding to the medication. Some of the related lab tests include the Anti Mullerian Hormone test, which is used to evaluate ovarian reserve and fertility potential in women. The Glycosylated Hemoglobin test, also known as HbA1c, is used to monitor long-term glucose control in individuals with diabetes. Testing Testosterone Total levels can help in assessing the function of the male sex hormone, while measuring Thyroid Stimulating Hormone levels can provide information about thyroid function. It is important to follow your healthcare provider's recommendations for these lab tests while taking Carryfine SR 300 Tablet to ensure optimal monitoring of your health.
Additional Information
Habit Forming | No |
Chemical Class | Progesterone Derivative |
Therapeutic Class | GYNAECOLOGICAL |
Action Class | Natural Progesterone |
FAQs
Disclaimer
The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.
₹535
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 11-Feb-2025